XNYS · Healthcare · Medical Devices
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-28 | Q1 2026 | 1.86 | 2.09 | +12.37% | $2.09B | ✅ Beat | +1.52% | +0.25% | +0.02% |
| 2026-02-10 | Q4 2025 | 2.39 | 2.42 | +1.26% | $2.24B | ✅ Beat | +1.42% | +6.29% | +1.30% |
| 2025-11-05 |
| Q3 2025 |
| 1.87 |
| 1.90 |
| +1.60% |
| $2.00B |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-07 | Q2 2025 | 1.98 | 2.07 | +4.55% | $2.08B | ✅ Beat | +1.48% | +3.75% | +7.42% |
| 2025-02-06 | Q4 2024 | 2.29 | 2.31 | +0.87% | $2.02B | ✅ Beat | -1.71% | -2.71% | +7.75% |
| 2024-08-07 | Q2 2024 | 1.99 | 2.01 | +1.01% | $1.94B | ✅ Beat | +2.73% | +2.67% | -0.95% |
| 2024-05-02 | Q1 2024 | 1.87 | 1.94 | +3.74% | $1.89B | ✅ Beat | +2.70% | +2.52% | -4.51% |
| 2024-02-08 | Q4 2023 | 2.15 | 2.20 | +2.33% | $1.94B | ✅ Beat | — | — | — |
Showing last 8 quarters.